Dysfunctional endothelium contributes to more diseases than any other tissue in the body. Small interfering RNAs (siRNAs) can help in the study and treatment of endothelial cells in vivo by durably silencing multiple genes simultaneously, but efficient siRNA delivery has so far remained challenging. Here, we show that polymeric nanoparticles made of low-molecular-weight polyamines and lipids can deliver siRNA to endothelial cells with high efficiency, thereby facilitating the simultaneous silencing of multiple endothelial genes in vivo. Unlike lipid or lipid-like nanoparticles, this formulation does not significantly reduce gene expression in hepatocytes or immune cells even at the dosage necessary for endothelial gene silencing. These nano...
Safe and effective delivery is required for siRNA and mRNA-based therapeutics to reach their potenti...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Chemical Engineering, 2018Catal...
Most delivery systems for small interfering RNA therapeutics depend on endocytosis and release from ...
Thesis: Ph. D., Harvard-MIT Program in Health Sciences and Technology, 2015.Cataloged from PDF versi...
Dysfunctional endothelial cells contribute to the pathophysiology of many diseases, including vascul...
Low transfection efficiency in endothelial cells (EC) is still a bottleneck for the majority of siRN...
The development of controlled-release nanoparticle (NP) technologies has great potential to further ...
In the thesis, Nanotechnology-based approaches for targeted delivery of siRNA or chemotherapeutics, ...
Bone marrow endothelial cells (BMECs) regulate their microenvironment, which includes hematopoietic ...
RNA interference is an evolutionarily conserved gene-silencing phenomenon that shows great promise f...
Increased insight in the role of endothelial cells in the pathophysiology of cancer, inflammatory an...
In recent years much research in RNA nanotechnology has been directed to develop an efficient and cl...
The endothelium represents an attractive therapeutic target due to its pivotal role in many diseases...
© 2020, The Author(s), under exclusive licence to Springer Nature Limited. Bone-marrow endothelial c...
The pivotal role of endothelial cells in the pathology of inflammatory diseases raised interest in t...
Safe and effective delivery is required for siRNA and mRNA-based therapeutics to reach their potenti...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Chemical Engineering, 2018Catal...
Most delivery systems for small interfering RNA therapeutics depend on endocytosis and release from ...
Thesis: Ph. D., Harvard-MIT Program in Health Sciences and Technology, 2015.Cataloged from PDF versi...
Dysfunctional endothelial cells contribute to the pathophysiology of many diseases, including vascul...
Low transfection efficiency in endothelial cells (EC) is still a bottleneck for the majority of siRN...
The development of controlled-release nanoparticle (NP) technologies has great potential to further ...
In the thesis, Nanotechnology-based approaches for targeted delivery of siRNA or chemotherapeutics, ...
Bone marrow endothelial cells (BMECs) regulate their microenvironment, which includes hematopoietic ...
RNA interference is an evolutionarily conserved gene-silencing phenomenon that shows great promise f...
Increased insight in the role of endothelial cells in the pathophysiology of cancer, inflammatory an...
In recent years much research in RNA nanotechnology has been directed to develop an efficient and cl...
The endothelium represents an attractive therapeutic target due to its pivotal role in many diseases...
© 2020, The Author(s), under exclusive licence to Springer Nature Limited. Bone-marrow endothelial c...
The pivotal role of endothelial cells in the pathology of inflammatory diseases raised interest in t...
Safe and effective delivery is required for siRNA and mRNA-based therapeutics to reach their potenti...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Chemical Engineering, 2018Catal...
Most delivery systems for small interfering RNA therapeutics depend on endocytosis and release from ...